Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer.
Selective overexpression of the MTDHdel enhanced murine and human ovarian cancer progression.
»
06/18/14
microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
ARL5A mRNA and protein levels were upregulated in colorectal cancer samples.
»
12/10/13
Silencing of e6/e7 expression in cervical cancer stem-like cells.
The significance of this approach is its specificity.
»
10/29/14
Activation of miR-9 by human papillomavirus in cervical cancer.
HPV-induced miR-9 activation led to significantly increased cell motility by downregulating multiple gene targets involved in cell migration.
»
10/27/14
GSTP1 arrests bladder cancer T24 cells in G0/G1 phase and up-regulates p21 expression.
GSTP1 over-expression showed significant reduction in cell proliferation.
»
11/02/14
ATF2 contributes to cisplatin resistance in Non-Small cell lung cancer and Celastrol induces cisplatin re-sensitization through inhibition of JNK/ATF2 pathway.
NSCLC ATF2 up-regulates at both mRNA/protein levels.
»
06/04/14
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells.
Hedgehog inhibition by NVP-LDE225 plus sunitinib or everolimus bolsters antitumour activity.
»
03/27/14
Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
Gli2 associates with chromatin at androgen response elements found near androgen-responsive genes in LNCaP cells.
»
04/24/14
Interferon regulatory factor 1 is an independent predictor of platinum resistance and survival in high-grade serous ovarian carcinoma.
IPA and URA highlighted an IRF1-driven transcriptional program.
»
04/14/14
Endothelin A receptor/Beta-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
Increased recruitment of Beta-arr1 and Beta-catenin to ET-1 gene promoter.
»
11/08/14
< Prev
Next >